| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459238 | Radiotherapy and Oncology | 2018 | 5 Pages |
Abstract
Progressive dose dependent perfusion loss is manifested on SPECT up to 12â¯months following IMRT. These findings suggest that the dynamic change in perfusion may have prognostic value in predicting radiation pneumonitis in NSCLC patients treated with IMRT.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Katherina P. Farr, Azza A. Khalil, Ditte S. Møller, Henrik Bluhme, Stine Kramer, Anni Morsing, Cai Grau,